Residual Tumor Potentially Left Behind After Local Ablation Therapy in Prostate Adenocarcinoma

Journal of Urology

Volumn 179, Issue 6, 2008, Pages 2203-2206

  Yoon, Ghil Suk ^a   Wang, Wenle ^a   Osunkoya, Adeboye O ^a   Lane, Zhaoli ^a   Partin, Alan W ^a   Epstein, Jonathan I ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

cryosurgery; prostatectomy; prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PROSTATIC NEOPLASMS;

EID: 43049111363     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.01.114     Document Type: Article

References (12)

1. Park P.C., Mai K.T., Roustan Delatour N.L., Morash C., and Cagiannos I. Predictive value of prostatic adenocarcinoma after a negative prostate biopsy. BJU Int 98 (2006) 986
2. DiGiuseppe J.A., Sauvageot J., and Epstein J.I. Increasing incidence of minimal residual cancer in radical prostatectomy specimens. Am J Surg Pathol 21 (1997) 174
3. Villers A., McNeal J.E., Freiha F.S., and Stamey T.A. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 70 (1992) 2313
4. Epstein J.I., Walsh P.C., Carmichael M., and Brendler C.B. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271 (1994) 368
5. Onik G. The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation. A review. Technol Cancer Res Treat 3 (2004) 365
6. Bahn D.K., Silverman P., Lee F.S., Badalament R., Bahn E.D., and Rewcastle J.C. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 20 (2006) 688
7. Mouraviev V., Mayes J.M., Sun L., Madden J.F., Moul J.W., and Polascik T.J. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 110 (2007) 906
8. Lambert E.H., Bolte K., Masson P., and Katz A.E. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology 69 (2007) 1117
9. Bastacky S.I., Wojno K.J., Walsh P.C., Carmichael M.J., and Epstein J.I. Pathological features of hereditary prostate cancer. J Urol 153 (1995) 987
10. Byar D.P., and Mostofi F.K. Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer 30 (1972) 5
11. Truskinovsky A.M., Sanderson H., and Epstein J.I. Characterization of minute adenocarcinomas of prostate at radical prostatectomy. Urology 64 (2004) 733
12. Djavan B., Susani M., Bursa B., Basharkhah A., Simak R., and Marberger M. Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen. Tech Urol 5 (1999) 139